{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:03:55Z","timestamp":1784070235349,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001810","name":"Research Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013455","name":"Lady Davis Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020986","name":"The Sir Mortimer B. Davis Jewish General Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020986","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35372","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T22:33:18Z","timestamp":1722378798000},"page":"e35372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of MSCs expressing islet neogenesis associated protein (INGAP): INGAP secretion and cell survival in vitro and in vivo"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2182-7096","authenticated-orcid":false,"given":"Maria","family":"Petropavlovskaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5556-6658","authenticated-orcid":false,"given":"Beatrice","family":"Assouline-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cuerquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Violette-Deslauriers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eni","family":"Nano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e35372_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00109-003-0450-y","article-title":"Inflammatory mediators and islet \u03b2-cell failure: a link between type 1 and type 2 diabetes","volume":"81","author":"Donath","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e35372_bib2","article-title":"Human beta cell regenerative drug therapy for diabetes: past achievements and future challenges","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35372_bib3","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","article-title":"Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3727\/096368912X647162","article-title":"Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice","volume":"22","author":"Gabr","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.heliyon.2024.e35372_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","article-title":"The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35372_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-015-9362-y","article-title":"Mesenchymal stem cells in the treatment of type 1 diabetes mellitus","volume":"26","author":"Katuchova","year":"2015","journal-title":"Endocr. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35372_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038189","article-title":"Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines","volume":"7","author":"Yeung","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13287-021-02342-5","article-title":"Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35372_bib9","first-page":"82","article-title":"A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus","volume":"7","author":"Cho","year":"2018","journal-title":"Am J Stem Cells"},{"key":"10.1016\/j.heliyon.2024.e35372_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5740923","article-title":"Efficacy and safety of stem cell therapy for T1DM: an updated systematic review and meta-analysis","volume":"2020","author":"Sun","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35372_bib11","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5966\/sctm.2015-0272","article-title":"Type 1 diabetes mellitus donor mesenchymal stromal cells exhibit comparable potency to healthy controls in vitro","volume":"5","author":"Davies","year":"2016","journal-title":"Stem cells translational medicine"},{"key":"10.1016\/j.heliyon.2024.e35372_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13287-015-0261-4","article-title":"Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties","volume":"7","author":"Yaochite","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35372_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35372_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","article-title":"Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus","volume":"17","author":"Thakkar","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.heliyon.2024.e35372_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12916-015-0426-0","article-title":"Mesenchymal stem\/stromal cells as a delivery platform in cell and gene therapies","volume":"13","author":"D'Souza","year":"2015","journal-title":"BMC Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35372_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077591","article-title":"Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation","volume":"8","author":"Mundra","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35372_bib17","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1172\/JCI119383","article-title":"Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters","volume":"99","author":"Rafaeloff","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/bmc.2011.055","article-title":"Regenerating proteins and their expression, regulation and signaling","volume":"3","author":"Parikh","year":"2012","journal-title":"Biomol. Concepts"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35372_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/193229680700100214","article-title":"The prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein (INGAP)","volume":"1","author":"Fleming A","year":"2007","journal-title":"Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2009.07.009","article-title":"Production and characterization of the recombinant islet neogenesis associated protein (rINGAP)","volume":"69","author":"Assouline-Thomas","year":"2010","journal-title":"Protein Expr. Purif."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35372_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/01.sla.0000143270.99191.10","article-title":"A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL\/6J mice","volume":"240","author":"Rosenberg","year":"2004","journal-title":"Ann. Surg."},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e35372_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.regpep.2009.05.011","article-title":"Islet neogenesis-associated protein pentadecapeptide (INGAP-PP): mechanisms involved in its effect upon beta-cell mass and function","volume":"157","author":"Madrid","year":"2009","journal-title":"Regul. Pept."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35372_bib23","doi-asserted-by":"crossref","first-page":"E917","DOI":"10.1152\/ajpendo.00670.2011","article-title":"Mechanisms of action of islet neogenesis-associated protein: comparison of the full-length recombinant protein and a bioactive peptide","volume":"303","author":"Petropavlovskaia","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"4\u20135","key":"10.1016\/j.heliyon.2024.e35372_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diff.2015.10.008","article-title":"Islet Neogenesis Associated Protein (INGAP) induces the differentiation of an adult human pancreatic ductal cell line into insulin-expressing cells through stepwise activation of key transcription factors for embryonic beta cell development","volume":"90","author":"Assouline-Thomas","year":"2015","journal-title":"Differentiation; research in biological diversity"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35372_bib25","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.peptides.2009.09.003","article-title":"Islet neogenesis-associated protein-related pentadecapeptide enhances the differentiation of islet-like clusters from human pancreatic duct cells","volume":"30","author":"Li","year":"2009","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35372_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/dmrr.999","article-title":"Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP)","volume":"25","author":"Dungan","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35372_bib27","first-page":"2384","article-title":"Vesicular stomatitis virus G pseudotyped retrovector mediates effective <em>in Vivo<\/em> suicide gene delivery in experimental","volume":"59","author":"Galipeau","year":"1999","journal-title":"Brain Cancer. Cancer Research"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35372_bib28","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1681\/ASN.2005101035","article-title":"Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure","volume":"17","author":"Eliopoulos","year":"2006","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41420-021-00441-z","article-title":"Islet neogenesis associated protein (INGAP) protects pancreatic beta cells from IL-1beta and IFNgamma-induced apoptosis","volume":"7","author":"Nano","year":"2021","journal-title":"Cell Death Discov"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35372_bib30","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/mt.2011.162","article-title":"Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice","volume":"19","author":"Eliopoulos","year":"2011","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35372_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35372_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2184.2000.00189.x","article-title":"Chaperones in cell cycle regulation and mitogenic signal transduction: a review","volume":"33","author":"Helmbrecht","year":"2000","journal-title":"Cell Prolif."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35372_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.gt.3301919","article-title":"A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice","volume":"10","author":"Eliopoulos","year":"2003","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35372_bib34","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-08-0160","article-title":"Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy","volume":"68","author":"Eliopoulos","year":"2008","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35372_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ymthe.2004.07.004","article-title":"Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells","volume":"10","author":"Eliopoulos","year":"2004","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35372_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051221","article-title":"Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment","volume":"7","author":"Rostovskaya","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35372_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1469-7580.2009.01065.x","article-title":"Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing","volume":"214","author":"Haasters","year":"2009","journal-title":"J. Anat."},{"key":"10.1016\/j.heliyon.2024.e35372_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8717694","article-title":"CD73 expression on mesenchymal stem cells dictates the reparative properties via its anti-inflammatory activity","volume":"2019","author":"Tan","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.heliyon.2024.e35372_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/678063","article-title":"Biodistribution of mesenchymal stem\/stromal cells in a preclinical setting","volume":"2013","author":"Sensebe","year":"2013","journal-title":"Stem Cells Int"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35372_bib40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/stem.3242","article-title":"Stem cell homing: from physiology to therapeutics","volume":"38","author":"Liesveld","year":"2020","journal-title":"Stem Cell."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s13287-021-02650-w","article-title":"Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e35372_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/632902","article-title":"Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy","volume":"2015","author":"Lee","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2024.e35372_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1089817","article-title":"Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses","volume":"11","author":"Lachaud","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35372_bib44","first-page":"634","article-title":"Effects of islet neogenesis-associated protein pentadecapeptide on cell mass and insulin secretion of pancreatic beta-cells","volume":"35","author":"Zha","year":"2012","journal-title":"J. Endocrinol. Invest."},{"issue":"11\u201312","key":"10.1016\/j.heliyon.2024.e35372_bib45","first-page":"1167","article-title":"Islet neogenesis-associated protein-related pentadecapeptide improves the function of allograft after islets transplantation","volume":"27","author":"Chen","year":"2014","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35372_bib46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1677\/joe.1.06698","article-title":"Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin","volume":"190","author":"Taylor-Fishwick","year":"2006","journal-title":"J. Endocrinol."},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e35372_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.regpep.2005.07.003","article-title":"INGAP-related pentadecapeptide: its modulatory effect upon insulin secretion","volume":"131","author":"Borelli","year":"2005","journal-title":"Regul. Pept."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35372_bib48","doi-asserted-by":"crossref","first-page":"F1474","DOI":"10.1152\/ajprenal.00512.2014","article-title":"Melatonin pretreatment of human adipose tissue-derived mesenchymal stromal cells enhances their prosurvival and protective effects on human kidney cells","volume":"308","author":"Zhao","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35372_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jcmm.14035","article-title":"Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury","volume":"23","author":"Zhao","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"31","key":"10.1016\/j.heliyon.2024.e35372_bib50","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.biomaterials.2007.07.041","article-title":"Self-assembled collagen-human mesenchymal stem cell microspheres for regenerative medicine","volume":"28","author":"Chan","year":"2007","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.heliyon.2024.e35372_bib51","article-title":"Sulfated alginate hydrogels prolong the therapeutic potential of MSC spheroids by sequestering the secretome","volume":"10","author":"Gionet-Gonzales","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.heliyon.2024.e35372_bib52","article-title":"Hydrogel encapsulation: taking the therapy of mesenchymal stem cells and their derived secretome to the Next level","volume":"10","author":"Huang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35372_bib53","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2007010044","article-title":"Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes","volume":"18","author":"Kunter","year":"2007","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35372_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12551-019-00528-z","article-title":"Frustrated differentiation of mesenchymal stem cells","volume":"11","author":"Kidoaki","year":"2019","journal-title":"Biophys Rev"},{"key":"10.1016\/j.heliyon.2024.e35372_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.actbio.2016.06.037","article-title":"Matrix directed adipogenesis and neurogenesis of mesenchymal stem cells derived from adipose tissue and bone marrow","volume":"42","author":"Lee","year":"2016","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/biores.2015.0044","article-title":"Heterogeneous differentiation of human mesenchymal stem cells in 3D extracellular matrix composites","volume":"5","author":"Jung","year":"2016","journal-title":"Biores Open Access"},{"issue":"33","key":"10.1016\/j.heliyon.2024.e35372_bib57","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1016\/j.biomaterials.2013.07.074","article-title":"Directing stem cell fate on hydrogel substrates by controlling cell geometry, matrix mechanics and adhesion ligand composition","volume":"34","author":"Lee","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35372_bib58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/br.2017.845","article-title":"Cell culture density affects the stemness gene expression of adipose tissue-derived mesenchymal stem cells","volume":"6","author":"Kim","year":"2017","journal-title":"Biomed Rep"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35372_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000240246","article-title":"Spontaneous differentiation of murine bone marrow-derived mesenchymal stem cells into adipocytes without malignant transformation after long-term culture","volume":"191","author":"Gou","year":"2010","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1134\/S1607672920020052","article-title":"Differential expression of bipotent commitment-related genes in multipotent mesenchymal stromal cells at different O(2) levels","volume":"491","author":"Buravkova","year":"2020","journal-title":"Dokl. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35372_bib61","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/stem.2365","article-title":"Vav1 regulates mesenchymal stem cell differentiation decision between adipocyte and chondrocyte via Sirt1","volume":"34","author":"Qu","year":"2016","journal-title":"Stem Cell."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35372_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00441-014-1830-z","article-title":"Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing","volume":"357","author":"Murphy","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35372_bib63","doi-asserted-by":"crossref","first-page":"773","DOI":"10.5966\/sctm.2015-0211","article-title":"Increased survival and function of mesenchymal stem cell spheroids entrapped in instructive alginate hydrogels","volume":"5","author":"Ho","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.heliyon.2024.e35372_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biomaterials.2017.06.019","article-title":"Biomaterials that promote cell-cell interactions enhance the paracrine function of MSCs","volume":"140","author":"Qazi","year":"2017","journal-title":"Biomaterials"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402411403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402411403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:09:07Z","timestamp":1784066947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402411403X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":64,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S240584402411403X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35372","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of MSCs expressing islet neogenesis associated protein (INGAP): INGAP secretion and cell survival in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e35372"}}